
Astek Diagnostics
Astek Diagnostics is a YC Summer 2021 (S21) company. Based in Baltimore, MD, USA. Team of 5.
About Astek Diagnostics
Summary
Astek Diagnostics builds a rapid clinical diagnostics platform, JIDDU, that confirms urinary tract infections and indicates antibiotic sensitivity within one hour by detecting bacterial oxygen consumption. Physicians currently wait days for standard culture results and often prescribe antibiotics by guesswork; JIDDU replaces that delay with point-of-care guidance. The platform targets a particularly high-stakes gap given that UTIs are a leading driver of sepsis and disproportionately affect women.
Go-to-market
The platform is aimed at clinical settings where physicians, particularly those managing infection-prone patients, need rapid point-of-care diagnostic support to guide antibiotic prescribing decisions.
From the Y Combinator listing
One-hour antibiotic sensitivity testing
Astek Diagnostics is building a platform (Eugris) that guides physicians in prescribing appropriate antibiotics for patients with bacterial sepsis in one hour. It is done by detecting the oxygen consumption of the bacteria
Facts
- Healthcare / Healthcare -> Diagnostics
- Baltimore, MD, USA
- 5
- Active
- Early
Founders (1)
- Mustafa Al-Adhami
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works